Skip to main content
Premium Trial:

Request an Annual Quote

Distribution Deals Brings Genaltye Maverick Detection System to Europe

NEW YORK (GenomeWeb News) – Genalyte today announced it has inked distribution deals for its Maverick Detection System covering parts of Europe.

The system, which analyzes multiple antibodies and other proteins, also received the CE Mark for research use in Europe.

San Diego-based Genalyte has reached distribution deals with Mokascience in France; Bucher Biotec in Switzerland; and KRD Molecular Technologies in the Czech Republic, Slovakia, and Hungary. The deals are the firm's first in Europe, it noted.

Financial and other terms of the agreements were not disclosed.

The Maverick Detection System uses a silicon chip with arrays of photonic ring sensors, and its workflow can deliver results in as little as 15 minutes from a small volume of sample of various types, Genalyte said.

Martin Gleeson, CSO of Genalyte, said in a statement that the company plans to launch several multiplex assays in the next few months and to announce additional distribution agreements "as we build a distribution network to reach pharmaceutical, biotechnology, and academic researchers around the globe."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.